Immucell(DE:IUL)
€9.00+0.20 (+2.27%)
DE:IUL
Immucell ownership
€9.00
At close:+0.20 (+2.27%)
Immucell (IUL) Ownership - Who Owns Immucell?
1 Followers
Immucell (IUL) Ownership Overview
- 4.07% Insiders
- 4.03% Mutual Funds
- 1.25% Other Institutional Investors
- 3.42% ETFs
- 87.24% Public Companies and Individual Investors
The ownership structure of Immucell (DE:IUL) stock is a mix of institutional, retail, and individual investors. Approximately 8.70% of the company’s stock is owned by Institutional Investors, 4.07% is owned by Insiders, and 87.24% is owned by Public Companies and Individual Investors.
The ownership structure of Immucell (DE:IUL) stock is a mix of institutional, retail, and individual investors. Approximately 8.70% of the company’s stock is owned by Institutional Investors, 4.07% is owned by Insiders, and 87.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Jun 21, 2026 | Paul Francis Olivier Te Boekhorst | $75,920 | |
| Dec 02, 2025 | Paul Francis Olivier Te Boekhorst | $48,547 | |
| Nov 27, 2025 | David Scott Tomsche | $15,546 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 260,064 | Institution | 2.86% | 2,596,999 |
| Vanguard Index Funds | 260,064 | Institution | 2.86% | 2,596,999 |
| Michael Brigham | 205,700 | Insider | 2.26% | 2,054,120 |
| David Scott Tomsche | 131,387 | Insider | 1.45% | 1,312,031 |
| Fidelity Concord Street Trust | 59,680 | Institution | 0.66% | 595,964 |
| Dfa | 28,394 | Institution | 0.31% | 283,542 |
| Dfa Investment Dimensions Group Inc | 28,337 | Institution | 0.31% | 282,973 |
| BlackRock, Inc. | 22,860 | Institution | 0.25% | 228,280 |
| Ishares | 19,152 | Institution | 0.21% | 191,252 |
| Paul Francis Olivier Te Boekhorst | 17,785 | Insider | 0.20% | 177,601 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 260,064 | Institution | 2.86% | 2,596,999 |
| Fidelity Concord Street Trust | 59,680 | Institution | 0.66% | 595,964 |
| Dfa Investment Dimensions Group Inc | 28,337 | Institution | 0.31% | 282,973 |
| Nationwide Mutual Funds | 10,102 | Institution | 0.11% | 100,879 |
| Vanguard Institutional Index Funds | 5,165 | Institution | 0.06% | 51,578 |
| Vanguard Valley Forge Funds | 2,901 | Institution | 0.03% | 28,969 |
FAQ
Who Owns Immucell (DE:IUL)?
According to the latest TipRanks data, approximately 8.70% of the company's stock is held by institutional investors, 4.07% is held by insiders, and 87.24% is held by public companies and individual investors.
What percentage of Immucell (DE:IUL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 8.70% of Immucell (DE:IUL) stock is held by institutional investors: 4.03% by mutual funds, 3.42% by ETFs and 1.25% by other institutional investors.
What percentage of Immucell (DE:IUL) stock is held by retail investors?
According to the latest TipRanks data, approximately 87.24% of Immucell (DE:IUL) stock is held by public companies and individual investors.
Who owns the most shares of Immucell (DE:IUL)?
Vanguard owns the most shares of Immucell (DE:IUL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
